Anebulo Pharmaceuticals, Inc. (15)

Browse by Contract Category

Contracts

Employment Agreement, effective as of May 20, 2022, between Anebulo Pharmaceuticals, Inc. and Kenneth Cundy (Filed With SEC on May 24, 2022)
Form of Underwriting Agreement (Filed With SEC on April 26, 2021)
Right of First Refusal and Co-Sale Agreement, dated June 18, 2020, between Anebulo Pharmaceuticals, Inc. and 22NW, LP (Filed With SEC on April 1, 2021)
License Agreement, dated May 26, 2020, between Vernalis (R&D) Limited and Anebulo Pharmaceuticals, Inc (Filed With SEC on April 1, 2021)
Form of Indemnification Agreement between Anebulo Pharmaceuticals, Inc. and each of its directors (Filed With SEC on April 1, 2021)
Employment Agreement, effective as of February 1, 2022, between Anebulo Pharmaceuticals, Inc. and Simon Allen (Filed With SEC on January 5, 2022)
Specimen Stock Certificate for Common Stock (Filed With SEC on April 1, 2021)
Warrant to Purchase Shares of Preferred Stock, dated as of March 8, 2021, between Anebulo Pharmaceuticals, Inc. and Aron English (Filed With SEC on April 1, 2021)
Warrant to Purchase Shares of Preferred Stock, dated as of March 8, 2021, between Anebulo Pharmaceuticals, Inc. and 22NW, LP (Filed With SEC on April 1, 2021)
Series A Preferred Stock Purchase Agreement, dated June 18, 2020, between Anebulo Pharmaceuticals, Inc. and 22NW, LP (Filed With SEC on April 1, 2021)
Investors Rights Agreement, dated June 18, 2020, between Anebulo Pharmaceuticals, Inc. and 22NW, LP (Filed With SEC on April 1, 2021)
Employment Agreement, dated July 21, 2020, between Daniel Schneeberger and Anebulo Pharmaceuticals, Inc (Filed With SEC on April 1, 2021)
Amendment No. 1 to Employment Agreement, dated January 22, 2021, between Daniel Schneeberger and Anebulo Pharmaceuticals, Inc (Filed With SEC on April 1, 2021)
Anebulo Pharmaceuticals, Inc. 2020 Stock Incentive Plan, and Form of Award Agreement thereunder (Filed With SEC on April 1, 2021)
Consultancy Agreement, dated July 15, 2020, between Anebulo Pharmaceuticals, Inc. and Traxeus Pharma Services Limited (Filed With SEC on April 1, 2021)